| Current Price | $3.73 | Mkt Cap | $396.9M |
|---|---|---|---|
| Open | $3.71 | P/E Ratio | -2.18 |
| Prev. Close | $3.73 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.59 - $3.79 | Volume | 3,278,314 |
| 52-Wk Range | $2.78 - $8.58 | Avg. Daily Vol. | 4,800,303 |
| Current Price | $3.73 | Mkt Cap | $396.9M |
|---|---|---|---|
| Open | $3.71 | P/E Ratio | -2.18 |
| Prev. Close | $3.73 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.59 - $3.79 | Volume | 3,278,314 |
| 52-Wk Range | $2.78 - $8.58 | Avg. Daily Vol. | 4,800,303 |
The best Bull and Bear pitches based on recency and number of recommendations.
From Fidelity or Zacks December 2021:Revenue Growth (Last 5 Years) = 77.9%Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%Price/Sales (TTM) = 14.2Re-establishing this position at a lower price.
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Read the most recent pitches from players about BLUE.
Recs
Car12703
(< 20)
Submitted: 12/20/2021 10:25:57 AM :
Start Price:
$8.32
NASDAQ:BLUE Score:
-49.42
From Fidelity or Zacks December 2021:
Revenue Growth (Last 5 Years) = 77.9%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%
Price/Sales (TTM) = 14.2
Re-establishing this position at a lower price.
Recs
Ficktory
(20.19)
Submitted: 12/13/2021 2:27:25 PM :
Start Price:
$9.36
NASDAQ:BLUE Score:
-51.46
Gene therapies will be a huge growth sector in health care in the next decade.
Recs
TMFacarchidi
(< 20)
Submitted: 12/1/2021 10:19:45 AM :
Start Price:
$10.58
NASDAQ:BLUE Score:
+57.06
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Find the members with the highest scoring picks in BLUE.
DoubleBagel (< 20) Score: +669.10
The Score Leader is the player with the highest score across all their picks in BLUE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| secohen11 | < 20 | 7/2/2013 |
|
1Y | $26.20 | -85.76% | +165.08% | +250.85 | 0 Comment | |
| saab93boi | < 20 | 6/19/2013 |
|
5Y | $25.68 | -85.47% | +159.78% | +245.25 | 0 Comment | |
| rwpaules | 77.99 | 6/19/2013 |
|
3Y | $25.09 | -85.13% | +158.10% | +243.23 | 0 Comment | |
| biotechf | 45.05 | 1/22/2016 |
|
3M | $44.44 | -91.61% | +125.59% | +217.20 | 0 Comment | |
| MotleyFolJohn | < 20 | 2/2/2015 |
|
1Y | $93.98 | -96.03% | +113.89% | +209.92 | 1 Comment | |
| cthomas1017 | 96.98 | 7/16/2014 |
|
5Y | $31.85 | -88.29% | +116.15% | +204.44 | 0 Comment | |
| 3rdChanceTom | 87.39 | 3/11/2016 |
|
5Y | $45.77 | -91.85% | +112.21% | +204.06 | 0 Comment | |
| pro64grammer | 28.19 | 12/9/2014 |
|
5Y | $79.58 | -95.31% | +108.66% | +203.97 | 0 Comment | |
|
CommodityBuyer | < 20 | 7/10/2015 |
|
5Y | $160.69 | -97.68% | +105.94% | +203.61 | 0 Comment |
| coptermech66 | < 20 | 10/29/2015 |
|
3Y | $79.54 | -95.31% | +104.54% | +199.85 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
